Industry Research Reports

Home > Reports > Medical Care > Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Industry: Medical Care

Published: 2023-05-25

Pages: 99 Pages

Report ld: 1211731

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

ICAD (Intracranial Atherosclerotic Disease) Pathology report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global ICAD (Intracranial Atherosclerotic Disease) Pathology market is projected to reach US$ 316.2 million in 2029, increasing from US$ 174 million in 2022, with the CAGR of 8.8% during the period of 2023 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global ICAD (Intracranial Atherosclerotic Disease) Pathology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Stryker
Balt
TERUMO
MicroPort
Acandis

Segment by Type
Stent
PTA Balloon

Segment by Application
Hospital
Clinic
Other

Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Each chapter of the report provides detailed information for readers to understand the ICAD (Intracranial Atherosclerotic Disease) Pathology market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of ICAD (Intracranial Atherosclerotic Disease) Pathology, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the ICAD (Intracranial Atherosclerotic Disease) Pathology industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, ICAD (Intracranial Atherosclerotic Disease) Pathology introduction, etc. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of ICAD (Intracranial Atherosclerotic Disease) Pathology market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview
    1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Overview
    1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Type
        1.2.1 Stent
        1.2.2 PTA Balloon
    1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
        1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Overview by Type (2018-2029)
        1.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size Review by Type (2018-2023)
        1.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2018-2023)
        1.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2018-2023)

 2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competition by Company
    2.1 Global Top Players by ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2018-2023)
    2.2 Global Top Players by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2018-2023)
    2.3 Global Top Players by ICAD (Intracranial Atherosclerotic Disease) Pathology Price (2018-2023)
    2.4 Global Top Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution, Sales Area, Product Type
    2.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitive Situation and Trends
        2.5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2022)
    2.7 Date of Key Manufacturers Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market
    2.8 Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Outlook by Region
    3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Region
        3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2018-2023)
        3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2018-2023)
        3.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Region
        3.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2024-2029)
        3.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2024-2029)
        3.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Application
    4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Other
    4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
        4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Overview by Application (2018-2029)
        4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size Review by Application (2018-2023)
        4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2018-2023)
        4.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2018-2023)

 5 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by Country
    5.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Country
        5.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2018-2023)
        5.1.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2018-2023)
    5.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Country
        5.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2024-2029)
        5.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2024-2029)

 6 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Country
    6.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Country
        6.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2018-2023)
        6.1.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2018-2023)
    6.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Country
        6.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2024-2029)
        6.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2024-2029)

 7 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by Region
    7.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Region
        7.1.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Region
        7.2.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2024-2029)

 8 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology by Country
    8.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Country
        8.1.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2018-2023)
        8.1.3 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2018-2023)
    8.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Country
        8.2.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2024-2029)
        8.2.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2024-2029)

 9 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Country
    9.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Country
        9.1.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Country
        9.2.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Stryker
        10.1.1 Stryker Company Information
        10.1.2 Stryker Introduction and Business Overview
        10.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
        10.1.5 Stryker Recent Development
    10.2 Balt
        10.2.1 Balt Company Information
        10.2.2 Balt Introduction and Business Overview
        10.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
        10.2.5 Balt Recent Development
    10.3 TERUMO
        10.3.1 TERUMO Company Information
        10.3.2 TERUMO Introduction and Business Overview
        10.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
        10.3.5 TERUMO Recent Development
    10.4 MicroPort
        10.4.1 MicroPort Company Information
        10.4.2 MicroPort Introduction and Business Overview
        10.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
        10.4.5 MicroPort Recent Development
    10.5 Acandis
        10.5.1 Acandis Company Information
        10.5.2 Acandis Introduction and Business Overview
        10.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
        10.5.5 Acandis Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain Analysis
    11.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
        11.4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
        11.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
        11.4.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
        11.4.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
    12.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Stent
    Table 2. Major Company of PTA Balloon
    Table 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (Units)
    Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (US& Million)
    Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in Value by Type (2018-2023)
    Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2018-2023) & (USD/Unit)
    Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2024-2029) & (Units)
    Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type (2024-2029)
    Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2024-2029) & (USD/Unit)
    Table 14. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (Units)
    Table 15. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Type (2018-2023)
    Table 17. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Type (2018-2023)
    Table 19. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Type (2018-2023)
    Table 21. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Type (2018-2023)
    Table 23. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2018-2023) & (Units)
    Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Company (2018-2023)
    Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Company (2018-2023)
    Table 28. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Company (2018-2023) & (USD/Unit)
    Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2022)
    Table 32. Date of Key Manufacturers Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market
    Table 33. Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2018-2023) & (Units)
    Table 37. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Region (2018-2023)
    Table 40. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 41. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2024-2029) & (Units)
    Table 42. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Region (2024-2029)
    Table 45. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 46. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (Units)
    Table 48. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2018-2023)
    Table 51. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2018-2023) & (USD/Unit)
    Table 52. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2024-2029) & (Units)
    Table 53. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2024-2029)
    Table 56. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2024-2029) & (USD/Unit)
    Table 57. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) (Units) 
    Table 58. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) (Units) 
    Table 60. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) (Units) 
    Table 62. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) (Units) 
    Table 64. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) (Units) 
    Table 66. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
    Table 68. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Country (2018-2023)
    Table 71. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (Units)
    Table 72. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
    Table 76. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (Units)
    Table 80. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2018-2023) & (Units)
    Table 84. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2024-2029) & (Units)
    Table 88. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
    Table 92. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (Units)
    Table 96. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
    Table 100. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (Units)
    Table 104. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Country (2024-2029)
    Table 107. Stryker Company Information
    Table 108. Stryker Introduction and Business Overview
    Table 109. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 110. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 111. Stryker Recent Development
    Table 112. Balt Company Information
    Table 113. Balt Introduction and Business Overview
    Table 114. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 115. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 116. Balt Recent Development
    Table 117. TERUMO Company Information
    Table 118. TERUMO Introduction and Business Overview
    Table 119. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 120. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 121. TERUMO Recent Development
    Table 122. MicroPort Company Information
    Table 123. MicroPort Introduction and Business Overview
    Table 124. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 125. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 126. MicroPort Recent Development
    Table 127. Acandis Company Information
    Table 128. Acandis Introduction and Business Overview
    Table 129. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 130. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 131. Acandis Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends
    Table 135. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
    Table 136. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
    Table 137. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
    Table 138. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
    Table 139. ICAD (Intracranial Atherosclerotic Disease) Pathology Downstream Customers
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture
    Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Status and Outlook (2018-2029) & (Units)
    Figure 5. Product Picture of Stent
    Figure 6. Global Stent Sales YoY Growth (2018-2029) & (Units)
    Figure 7. Product Picture of PTA Balloon
    Figure 8. Global PTA Balloon Sales YoY Growth (2018-2029) & (Units)
    Figure 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2022 & 2029
    Figure 11. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2022
    Figure 12. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2022
    Figure 13. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2022
    Figure 14. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2022
    Figure 17. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2022
    Figure 23. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Hospital
    Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (Units)
    Figure 26. Product Picture of Clinic
    Figure 27. Global Clinic Sales YoY Growth (2018-2029) & (Units)
    Figure 28. Product Picture of Other
    Figure 29. Global Other Sales YoY Growth (2018-2029) & (Units)
    Figure 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2029) & (US$ Million)
    Figure 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application in 2022 & 2029
    Figure 32. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application in 2022
    Figure 33. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application in 2022
    Figure 34. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application in 2022
    Figure 35. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application in 2022
    Figure 36. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application in 2022
    Figure 37. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application in 2022
    Figure 38. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application in 2022
    Figure 39. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application in 2022
    Figure 40. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Cost Structure
    Figure 43. ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

ICAD (Intracranial Atherosclerotic Disease) Pathology report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global ICAD (Intracranial Atherosclerotic Disease) Pathology market is projected to reach US$ 316.2 million in 2029, increasing from US$ 174 million in 2022, with the CAGR of 8.8% during the period of 2023 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Stryker
Balt
TERUMO
MicroPort
Acandis

Segment by Type
Stent
PTA Balloon

Segment by Application
Hospital
Clinic
Other

Industry: Medical Care

Published: 2023-05-25

Pages: 99 Pages

Report ld: 1211731

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License

USD 5025.00

Corporate Users License

USD 6700.00

/uploads/payment/payIcon/masterCard-01.svg

/uploads/payment/payIcon/american-express-01.svg

/uploads/payment/payIcon/diners-club-01.svg

/uploads/payment/payIcon/discover-4-01.svg

Add to Cart

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

Speak To Our Analyst >>

WHAT QYRESEARCH OFFER?